Revance Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACLX
Arcellx, Inc. |
$79.24 | $2.72 B | -49.3 | 130 | $110.32 M |
AKRO
Akero Therapeutics, Inc. |
$28.10 | $1.59 B | -7.1 | 60 | $0 |
AMLX
Amylyx Pharmaceuticals, Inc. |
$3.97 | $120.37 M | -1.65 | 384 | $380.79 M |
APLS
Apellis Pharmaceuticals, Inc. |
$32.46 | $4.90 B | -11.77 | 702 | $396.59 M |
BPMC
Blueprint Medicines Corporation |
$88.54 | $6.47 B | -21.48 | 638 | $249.38 M |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
DAWN
Day One Biopharmaceuticals, Inc. |
$12.92 | $1.12 B | -5.11 | 174 | $0 |
DMAC
DiaMedica Therapeutics Inc. |
$5.55 | $97.19 M | -4.74 | 18 | $0 |
ETNB
89bio, Inc. |
$7.93 | $796.91 M | -4.05 | 70 | $0 |
IMCR
Immunocore Holdings plc |
$29.71 | $2.08 B | -26.72 | 497 | $249.43 M |
ISEE
IVERIC bio, Inc. |
$39.95 | $5.51 B | -22.44 | 163 | $0 |
KRTX
Karuna Therapeutics, Inc. |
$329.83 | $12.60 B | -28.09 | 339 | $654,000 |
MDGL
Madrigal Pharmaceuticals, Inc. |
$318.24 | $5.21 B | -10.55 | 376 | $0 |
NUVL
Nuvalent, Inc. |
$79.76 | $5.11 B | -32.72 | 127 | $0 |
PLRX
Pliant Therapeutics, Inc. |
$12.96 | $672.63 M | -3.9 | 166 | $1.58 M |
STOK
Stoke Therapeutics, Inc. |
$11.48 | $774.50 M | -6.14 | 110 | $8.78 M |
TERN
Terns Pharmaceuticals, Inc. |
$5.68 | $462.44 M | -5.67 | 66 | $0 |
VTYX
Ventyx Biosciences, Inc. |
$2.23 | $229.83 M | -1.01 | 75 | $0 |